Efficacy and Safety Results of Atrasentan in Patients With Iga Nephropathy on Sodium‚äìglucose Co-transporter 2 Inhibitors: Phase II, Randomized, Placebo-controlled, Crossover Trial (ASSIST)

29 Mar 2026 2:10 p.m. 2:25 p.m.
JanakaKaralliedde Speaker United Kingdom